Antonella Di Caprio , Cecilia Rossi , Emma Bertucci , Luca Bedetti , Natascia Bertoncelli , Francesca Miselli , Lucia Corso , Carolina Bondi , Lorenzo Iughetti , Alberto Berardi , Licia Lugli
{"title":"严重 KAT6A(Arboleda-Tham)综合征的胎儿肝钙化","authors":"Antonella Di Caprio , Cecilia Rossi , Emma Bertucci , Luca Bedetti , Natascia Bertoncelli , Francesca Miselli , Lucia Corso , Carolina Bondi , Lorenzo Iughetti , Alberto Berardi , Licia Lugli","doi":"10.1016/j.ejmg.2023.104906","DOIUrl":null,"url":null,"abstract":"<div><p>Arboleda-Tham syndrome (ARTHS, MIM 616268) is a rare genetic disease, due to a pathogenic variant of Lysine (K) Acetyltransferase 6A (<em>KAT6A</em>) with autosomal dominant inheritance. Firstly described in 2015, ARTHS is one of the more common causes of undiagnosed syndromic intellectual disability. Due to extreme phenotypic variability, ARTHS clinical diagnosis is challenging, mostly at early stage of the disease. Moreover, because of the wide and unspecific spectrum of ARTHS, identification of the syndrome during prenatal life rarely occurs. Therefore, reported cases of <em>KAT6A</em> syndrome have been identified primarily through clinical or research exome sequencing in a gene-centric approach.</p><p>In order to expands the genotypic and phenotypic spectrum of ARTHS, we describe prenatal and postnatal findings in a patient with a novel frameshift <em>KAT6A</em> pathogenic variant, displaying a severe phenotype with previously unreported clinical features.</p></div>","PeriodicalId":11916,"journal":{"name":"European journal of medical genetics","volume":"67 ","pages":"Article 104906"},"PeriodicalIF":1.6000,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1769721223002124/pdfft?md5=4e32d8a31f826a15255c7f3521c22167&pid=1-s2.0-S1769721223002124-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Fetal hepatic calcification in severe KAT6A (Arboleda-Tham) syndrome\",\"authors\":\"Antonella Di Caprio , Cecilia Rossi , Emma Bertucci , Luca Bedetti , Natascia Bertoncelli , Francesca Miselli , Lucia Corso , Carolina Bondi , Lorenzo Iughetti , Alberto Berardi , Licia Lugli\",\"doi\":\"10.1016/j.ejmg.2023.104906\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Arboleda-Tham syndrome (ARTHS, MIM 616268) is a rare genetic disease, due to a pathogenic variant of Lysine (K) Acetyltransferase 6A (<em>KAT6A</em>) with autosomal dominant inheritance. Firstly described in 2015, ARTHS is one of the more common causes of undiagnosed syndromic intellectual disability. Due to extreme phenotypic variability, ARTHS clinical diagnosis is challenging, mostly at early stage of the disease. Moreover, because of the wide and unspecific spectrum of ARTHS, identification of the syndrome during prenatal life rarely occurs. Therefore, reported cases of <em>KAT6A</em> syndrome have been identified primarily through clinical or research exome sequencing in a gene-centric approach.</p><p>In order to expands the genotypic and phenotypic spectrum of ARTHS, we describe prenatal and postnatal findings in a patient with a novel frameshift <em>KAT6A</em> pathogenic variant, displaying a severe phenotype with previously unreported clinical features.</p></div>\",\"PeriodicalId\":11916,\"journal\":{\"name\":\"European journal of medical genetics\",\"volume\":\"67 \",\"pages\":\"Article 104906\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2023-12-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1769721223002124/pdfft?md5=4e32d8a31f826a15255c7f3521c22167&pid=1-s2.0-S1769721223002124-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of medical genetics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1769721223002124\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of medical genetics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1769721223002124","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Fetal hepatic calcification in severe KAT6A (Arboleda-Tham) syndrome
Arboleda-Tham syndrome (ARTHS, MIM 616268) is a rare genetic disease, due to a pathogenic variant of Lysine (K) Acetyltransferase 6A (KAT6A) with autosomal dominant inheritance. Firstly described in 2015, ARTHS is one of the more common causes of undiagnosed syndromic intellectual disability. Due to extreme phenotypic variability, ARTHS clinical diagnosis is challenging, mostly at early stage of the disease. Moreover, because of the wide and unspecific spectrum of ARTHS, identification of the syndrome during prenatal life rarely occurs. Therefore, reported cases of KAT6A syndrome have been identified primarily through clinical or research exome sequencing in a gene-centric approach.
In order to expands the genotypic and phenotypic spectrum of ARTHS, we describe prenatal and postnatal findings in a patient with a novel frameshift KAT6A pathogenic variant, displaying a severe phenotype with previously unreported clinical features.
期刊介绍:
The European Journal of Medical Genetics (EJMG) is a peer-reviewed journal that publishes articles in English on various aspects of human and medical genetics and of the genetics of experimental models.
Original clinical and experimental research articles, short clinical reports, review articles and letters to the editor are welcome on topics such as :
• Dysmorphology and syndrome delineation
• Molecular genetics and molecular cytogenetics of inherited disorders
• Clinical applications of genomics and nextgen sequencing technologies
• Syndromal cancer genetics
• Behavioral genetics
• Community genetics
• Fetal pathology and prenatal diagnosis
• Genetic counseling.